TREATMENT OPTIONS IN ONCOLOGY:@0.084848:0.038601:0.493541:0.038601:0.493541:0.019343:0.084848:0.019343:0.010019:0.014276:0.012606:0.015487:0.010019:0.021613:0.012606:0.017404:0.010019:0.006515:0.020438:0.013923:0.010019:0.005315:0.020438:0.017404:0.011712:0.006515:0.005315:0.017404:0.006515:0.020438:0.017404:0.019121:0.020438:0.010866:0.020438:0.020508:0.013923
24:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Dr IO Lawal:@0.084848:0.219082:0.190682:0.219082:0.190682:0.203049:0.084848:0.203049:0.013470:0.006158:0.005388:0.005388:0.016164:0.005388:0.008467:0.012700:0.015394:0.012700:0.004618
MBBS, FCNP, MMed(Nucl Med):@0.084848:0.235381:0.370021:0.235381:0.370021:0.219162:0.084848:0.219162:0.017318:0.011161:0.011161:0.010006:0.005388:0.005388:0.009236:0.015009:0.014239:0.010776:0.005388:0.005388:0.017318:0.017318:0.012315:0.012700:0.007312:0.014239:0.011545:0.012315:0.004618:0.005388:0.017318:0.012315:0.012700:0.007312
 :@0.084848:0.251560:0.121236:0.251560:0.121236:0.236876:0.084848:0.236876:0.017145:0.019242
Nuclear Medicine Physician, :@0.121236:0.251679:0.389937:0.251679:0.389937:0.235923:0.121236:0.235923:0.014239:0.011699:0.012450:0.003848:0.012508:0.013143:0.005792:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.011392:0.011738:0.010314:0.007466:0.003848:0.012450:0.003848:0.013143:0.011738:0.005330:0.005330
Department of Nuclear Medicine, :@0.084848:0.267977:0.405812:0.267977:0.405812:0.252221:0.084848:0.252221:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.014239:0.011699:0.012450:0.003848:0.012508:0.013143:0.005792:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.005330
University of Pretoria and Steve Biko :@0.084848:0.284276:0.419285:0.284276:0.419285:0.268520:0.084848:0.268520:0.012604:0.011738:0.003848:0.010660:0.012508:0.005792:0.007466:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330:0.011392:0.005700:0.012508:0.006523:0.012604:0.005792:0.003848:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.009583:0.006523:0.012508:0.010660:0.012508:0.005330:0.011045:0.003848:0.009660:0.012604:0.005330
Academic Hospital:@0.084848:0.300574:0.263745:0.300574:0.263745:0.284818:0.084848:0.284818:0.014239:0.012450:0.013143:0.013181:0.012508:0.018049:0.003848:0.012450:0.005330:0.013143:0.012604:0.007466:0.013123:0.003848:0.006523:0.013143:0.003848
Prof MM Sathekge:@0.084848:0.333171:0.253412:0.333171:0.253412:0.317137:0.084848:0.317137:0.010776:0.006158:0.012315:0.005388:0.005388:0.017318:0.017318:0.005388:0.010006:0.012700:0.005773:0.011545:0.012315:0.011161:0.012700:0.012315
MB ChB, MMed (Nucl Med), FAMS, PhD:@0.084848:0.349469:0.445451:0.349469:0.445451:0.333250:0.084848:0.333250:0.017318:0.011161:0.005388:0.015009:0.011545:0.011161:0.005388:0.005388:0.017318:0.017318:0.012315:0.012700:0.005388:0.007312:0.014239:0.011545:0.012315:0.004618:0.005388:0.017318:0.012315:0.012700:0.007312:0.005388:0.005388:0.009236:0.014239:0.017318:0.010006:0.005388:0.005388:0.010776:0.011545:0.013470
 :@0.084848:0.365648:0.121236:0.365648:0.121236:0.350964:0.084848:0.350964:0.017145:0.019242
Professor and Head of Department, :@0.121236:0.365767:0.457703:0.365767:0.457703:0.350011:0.121236:0.350011:0.011392:0.005709:0.012604:0.006042:0.012508:0.007466:0.007466:0.012604:0.005792:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.012508:0.013143:0.013181:0.005330:0.012604:0.006042:0.005330:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330
Department of Nuclear Medicine, :@0.084848:0.382066:0.405812:0.382066:0.405812:0.366310:0.084848:0.366310:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.014239:0.011699:0.012450:0.003848:0.012508:0.013143:0.005792:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.005330
University of Pretoria and Steve Biko :@0.084848:0.398364:0.419285:0.398364:0.419285:0.382608:0.084848:0.382608:0.012604:0.011738:0.003848:0.010660:0.012508:0.005792:0.007466:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330:0.011392:0.005700:0.012508:0.006523:0.012604:0.005792:0.003848:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.009583:0.006523:0.012508:0.010660:0.012508:0.005330:0.011045:0.003848:0.009660:0.012604:0.005330
Academic Hospital:@0.084848:0.414662:0.263745:0.414662:0.263745:0.398906:0.084848:0.398906:0.014239:0.012450:0.013143:0.013181:0.012508:0.018049:0.003848:0.012450:0.005330:0.013143:0.012604:0.007466:0.013123:0.003848:0.006523:0.013143:0.003848
Corresponding author: Prof MM Sathekge:@0.084848:0.447259:0.471598:0.447259:0.471598:0.431503:0.084848:0.431503:0.015644:0.012604:0.005792:0.005703:0.012508:0.007466:0.013123:0.012604:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330:0.013143:0.011699:0.006523:0.011738:0.012604:0.005792:0.005330:0.005330:0.011392:0.005684:0.012604:0.006042:0.005330:0.017684:0.017684:0.005330:0.009583:0.013143:0.006523:0.011738:0.012508:0.009660:0.012950:0.012508
Targeted  cancer  therapy  relies on  the :@0.084848:0.479856:0.481098:0.479856:0.481098:0.464100:0.084848:0.464100:0.007197:0.013143:0.005809:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.007641:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.007641:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.007645:0.005713:0.012508:0.003848:0.003848:0.012508:0.007466:0.012989:0.012604:0.011738:0.005330:0.007643:0.006523:0.011738:0.012508:0.005330
identification of a biological target in the :@0.084848:0.496154:0.481096:0.496154:0.481096:0.480398:0.084848:0.480398:0.003848:0.013181:0.012508:0.011738:0.006523:0.003848:0.004686:0.004686:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.006950:0.012604:0.006042:0.006950:0.013143:0.006958:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.006964:0.006523:0.013143:0.005809:0.012950:0.012508:0.006523:0.006948:0.003848:0.011738:0.006956:0.006523:0.011738:0.012508:0.005330
tumour and optimising it for therapeutic in-:@0.084848:0.512452:0.475764:0.512452:0.475764:0.496696:0.084848:0.496696:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.004297:0.013143:0.011738:0.013181:0.004310:0.012604:0.013123:0.006523:0.003848:0.018049:0.003848:0.007466:0.003848:0.011738:0.012950:0.004310:0.003848:0.006523:0.004310:0.006042:0.012604:0.005792:0.004310:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.004310:0.003848:0.011738:0.006388
tervention. A candidate biological target :@0.084848:0.528751:0.481084:0.528751:0.481084:0.512995:0.084848:0.512995:0.006523:0.012508:0.005792:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330:0.006852:0.014239:0.006870:0.012450:0.013143:0.011738:0.013181:0.003848:0.013181:0.013143:0.006523:0.012508:0.006870:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.006870:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.005330
should be expressed exclusively by the tu-:@0.084848:0.545049:0.475746:0.545049:0.475746:0.529293:0.084848:0.529293:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005638:0.013123:0.012508:0.005638:0.012508:0.009236:0.013123:0.005713:0.012508:0.007466:0.007466:0.012508:0.013181:0.005638:0.012508:0.009236:0.012450:0.003848:0.011699:0.007466:0.003848:0.010660:0.012508:0.003848:0.010314:0.005638:0.013123:0.010314:0.005638:0.006523:0.011738:0.012508:0.005628:0.006523:0.011699:0.006388
mour or must have only low-level expres-:@0.084848:0.561347:0.475735:0.561347:0.475735:0.545591:0.084848:0.545591:0.018049:0.012604:0.011699:0.005792:0.007485:0.012604:0.005792:0.007485:0.018049:0.011699:0.007466:0.006523:0.007485:0.011738:0.013143:0.010660:0.012508:0.007485:0.012604:0.011738:0.003848:0.010314:0.007485:0.003848:0.012604:0.015990:0.006388:0.003848:0.012508:0.010660:0.012508:0.003848:0.007485:0.012508:0.009236:0.013123:0.005711:0.012508:0.007466:0.006388
sion in non-malignant tissues. A pharma-:@0.084848:0.577646:0.475773:0.577646:0.475773:0.561890:0.084848:0.561890:0.007466:0.003848:0.012604:0.011738:0.008755:0.003848:0.011738:0.008755:0.011738:0.012604:0.011738:0.006388:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.008755:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.005330:0.008755:0.014239:0.008755:0.013123:0.011738:0.013143:0.006327:0.018049:0.013143:0.006388
ceutical molecule is designed to  target :@0.084848:0.593944:0.481094:0.593944:0.481094:0.578188:0.084848:0.578188:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.010333:0.018049:0.012604:0.003848:0.012508:0.012450:0.011699:0.003848:0.012508:0.010333:0.003848:0.007466:0.010333:0.013181:0.012508:0.007466:0.003848:0.012950:0.011738:0.012508:0.013181:0.010333:0.006523:0.012604:0.005330:0.004993:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.005330
the tumour-expressed biological marker.:@0.084848:0.610242:0.459177:0.610242:0.459177:0.594486:0.084848:0.594486:0.006523:0.011738:0.012508:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006388:0.012508:0.009236:0.013123:0.005690:0.012508:0.007466:0.007466:0.012508:0.013181:0.005330:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.018049:0.013143:0.005792:0.009660:0.012508:0.004380:0.005330
For  targeted radionuclide therapy of :@0.103032:0.626541:0.481109:0.626541:0.481109:0.610785:0.103032:0.610785:0.009333:0.012604:0.005792:0.005330:0.007724:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.013066:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.013066:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.013066:0.012604:0.006042:0.005330
cancers,  a  radionuclide,  which  emits a :@0.084848:0.642839:0.481094:0.642839:0.481094:0.627083:0.084848:0.627083:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.005330:0.005948:0.013143:0.005330:0.005956:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.005330:0.005952:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.005954:0.012508:0.018049:0.003848:0.006523:0.007466:0.011295:0.013143:0.005330
beta, or more recently, an alpha particle, :@0.084848:0.659137:0.481109:0.659137:0.481109:0.643381:0.084848:0.643381:0.013123:0.012508:0.006523:0.013143:0.005330:0.005946:0.012604:0.005792:0.005946:0.018049:0.012604:0.005709:0.012508:0.005946:0.005713:0.012508:0.012450:0.012508:0.011738:0.006523:0.003848:0.010314:0.005330:0.005936:0.013143:0.011738:0.005946:0.013143:0.003848:0.013123:0.011738:0.013143:0.005946:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.003848:0.012508:0.005330:0.005330
is complexed to the pharmaceutical to :@0.084848:0.675436:0.481101:0.675436:0.481101:0.659680:0.084848:0.659680:0.003848:0.007466:0.010218:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.009236:0.012508:0.013181:0.010218:0.006523:0.012604:0.010218:0.006523:0.011738:0.012508:0.010218:0.013123:0.011738:0.013143:0.006325:0.018049:0.013143:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.010218:0.006523:0.012604:0.005330
form a therapeutic radiopharmaceutical. :@0.084848:0.691734:0.481086:0.691734:0.481086:0.675978:0.084848:0.675978:0.006042:0.012604:0.006319:0.018049:0.006338:0.013143:0.006340:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.006331:0.005792:0.013143:0.013181:0.003848:0.012604:0.013123:0.011738:0.013143:0.006323:0.018049:0.013143:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.005330:0.005330
Beta and alpha particles are two energetic :@0.084848:0.708032:0.481049:0.708032:0.481049:0.692276:0.084848:0.692276:0.011045:0.012508:0.006523:0.013143:0.003098:0.013143:0.011738:0.013181:0.003098:0.013143:0.003848:0.013123:0.011738:0.013143:0.003098:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.003848:0.012508:0.007466:0.003098:0.013143:0.005715:0.012508:0.003098:0.006523:0.015990:0.012604:0.003098:0.012508:0.011738:0.012508:0.005792:0.012950:0.012508:0.006523:0.003848:0.012450:0.005330
particles that are capable of causing DNA :@0.084848:0.724331:0.481103:0.724331:0.481103:0.708575:0.084848:0.708575:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.003848:0.012508:0.007466:0.004483:0.006523:0.011738:0.013143:0.006523:0.004468:0.013143:0.005711:0.012508:0.004474:0.012450:0.013143:0.013123:0.013143:0.013123:0.003848:0.012508:0.004483:0.012604:0.006042:0.004470:0.012450:0.013143:0.011699:0.007466:0.003848:0.011738:0.012950:0.004483:0.014316:0.014239:0.014239:0.005330
damage, leading to death of the tumour :@0.084848:0.740629:0.481111:0.740629:0.481111:0.724873:0.084848:0.724873:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.005330:0.006567:0.003848:0.012508:0.013143:0.013181:0.003848:0.011738:0.012950:0.006581:0.006523:0.012604:0.006564:0.013181:0.012508:0.013143:0.006523:0.011738:0.006567:0.012604:0.006042:0.006569:0.006523:0.011738:0.012508:0.006564:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
cells. Following :@0.084848:0.756927:0.229955:0.756927:0.229955:0.741171:0.084848:0.741171:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.007562:0.009333:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330
in vivo:@0.232187:0.756927:0.293109:0.756927:0.293109:0.741171:0.232187:0.741171:0.003848:0.011738:0.007562:0.010660:0.003848:0.010660:0.012604
 administration, the :@0.293109:0.756927:0.481107:0.756927:0.481107:0.741171:0.293109:0.741171:0.007562:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.007562:0.006523:0.011738:0.012508:0.005330
radiopharmaceutical is distributed to the :@0.084848:0.773226:0.481090:0.773226:0.481090:0.757470:0.084848:0.757470:0.005792:0.013143:0.013181:0.003848:0.012604:0.013123:0.011738:0.013143:0.006323:0.018049:0.013143:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.007870:0.003848:0.007466:0.007870:0.013181:0.003848:0.007466:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.012508:0.013181:0.007857:0.006523:0.012604:0.007855:0.006523:0.011738:0.012508:0.005330
tumour and the radiation released by the :@0.084848:0.789524:0.481090:0.789524:0.481090:0.773768:0.084848:0.773768:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006123:0.013143:0.011738:0.013181:0.006138:0.006523:0.011738:0.012508:0.006138:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006138:0.005713:0.012508:0.003848:0.012508:0.013143:0.007466:0.012508:0.013181:0.006138:0.013123:0.010314:0.006138:0.006523:0.011738:0.012508:0.005330
radionuclide causes tumour-cell death. :@0.084848:0.805822:0.481094:0.805822:0.481094:0.790066:0.084848:0.790066:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.013508:0.012450:0.013143:0.011699:0.007466:0.012508:0.007466:0.013508:0.006523:0.011699:0.018049:0.012604:0.011699:0.005778:0.006388:0.012450:0.012508:0.003848:0.003848:0.013508:0.013181:0.012508:0.013143:0.006523:0.011738:0.005330:0.005330
Theoretically, any tumour can be treated :@0.084848:0.822121:0.481105:0.822121:0.481105:0.806365:0.084848:0.806365:0.008197:0.011738:0.012508:0.012604:0.005700:0.012508:0.006523:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.006754:0.013143:0.011738:0.010314:0.006754:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.006733:0.012450:0.013143:0.011738:0.006754:0.013123:0.012508:0.006754:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330
using targeted radionuclide technique :@0.084848:0.838419:0.481121:0.838419:0.481121:0.822663:0.084848:0.822663:0.011699:0.007466:0.003848:0.011738:0.012950:0.015375:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.015375:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.015375:0.006523:0.012508:0.012450:0.011738:0.011738:0.003848:0.013123:0.011699:0.012508:0.005330
once  a suitable biological target  that  is :@0.084848:0.854717:0.481080:0.854717:0.481080:0.838961:0.084848:0.838961:0.012604:0.011738:0.012450:0.012508:0.005330:0.004218:0.013143:0.009563:0.007466:0.011699:0.003848:0.006523:0.013143:0.013123:0.003848:0.012508:0.009563:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.009563:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.005330:0.004220:0.006523:0.011738:0.013143:0.006523:0.005330:0.004222:0.003848:0.007466:0.005330
over-expressed by  that tumour  is  identi-:@0.084848:0.871016:0.475746:0.871016:0.475746:0.855260:0.084848:0.855260:0.012604:0.010660:0.012508:0.005792:0.006388:0.012508:0.009236:0.013123:0.005707:0.012508:0.007466:0.007466:0.012508:0.013181:0.010429:0.013123:0.010314:0.005330:0.005111:0.006523:0.011738:0.013143:0.006523:0.010429:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.005090:0.003848:0.007466:0.005330:0.005113:0.003848:0.013181:0.012508:0.011738:0.006523:0.003848:0.006388
fied and a radiopharmaceutical target is :@0.084848:0.887314:0.481080:0.887314:0.481080:0.871558:0.084848:0.871558:0.004686:0.004686:0.012508:0.013181:0.007060:0.013143:0.011738:0.013181:0.007064:0.013143:0.007066:0.005792:0.013143:0.013181:0.003848:0.012604:0.013123:0.011738:0.013143:0.006323:0.018049:0.013143:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.007068:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.007056:0.003848:0.007466:0.005330
designed for its :@0.084848:0.903612:0.236005:0.903612:0.236005:0.887856:0.084848:0.887856:0.013181:0.012508:0.007466:0.003848:0.012950:0.011738:0.012508:0.013181:0.008090:0.006042:0.012604:0.005792:0.008082:0.003848:0.006523:0.007466:0.005330
in vivo:@0.238776:0.903612:0.300227:0.903612:0.300227:0.887856:0.238776:0.887856:0.003848:0.011738:0.008091:0.010660:0.003848:0.010660:0.012604
 targeting. Several :@0.300227:0.903612:0.481090:0.903612:0.481090:0.887856:0.300227:0.887856:0.008090:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.003848:0.011738:0.012950:0.005330:0.008084:0.009583:0.012508:0.010660:0.012508:0.005792:0.013143:0.003848:0.005330
radionuclide agents have been designed :@0.084848:0.919911:0.481099:0.919911:0.481099:0.904155:0.084848:0.904155:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005869:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005854:0.011738:0.013143:0.010660:0.012508:0.005869:0.013123:0.012508:0.012508:0.011738:0.005857:0.013181:0.012508:0.007466:0.003848:0.012950:0.011738:0.012508:0.013181:0.005330
for treatment of different human cancers.:@0.084848:0.936209:0.473179:0.936209:0.473179:0.920453:0.084848:0.920453:0.006042:0.012604:0.005792:0.005330:0.006523:0.005698:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.013181:0.003848:0.006083:0.006042:0.012508:0.005711:0.012508:0.011738:0.006523:0.005330:0.011738:0.011699:0.018049:0.013143:0.011738:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330
Theranostics  is  a  concept  closely  related :@0.524249:0.219043:0.920494:0.219043:0.920494:0.203287:0.524249:0.203287:0.007620:0.011161:0.011930:0.005215:0.012565:0.011161:0.012027:0.006889:0.005946:0.003271:0.011873:0.006889:0.005330:0.006935:0.003271:0.006889:0.005330:0.006935:0.012565:0.005330:0.006937:0.011873:0.012027:0.011161:0.011873:0.011930:0.012546:0.005946:0.005330:0.006937:0.011873:0.003271:0.012027:0.006889:0.011930:0.003271:0.009737:0.005330:0.006937:0.005136:0.011930:0.003271:0.012565:0.005946:0.011930:0.013183:0.005330
to targeted therapy. Theranostics is a com-:@0.524249:0.235341:0.915152:0.235341:0.915152:0.219585:0.524249:0.219585:0.005946:0.012027:0.007254:0.005946:0.012565:0.005228:0.012373:0.011930:0.005946:0.011930:0.012604:0.007254:0.005946:0.011161:0.011930:0.005215:0.012565:0.012546:0.009737:0.004753:0.007254:0.007620:0.011161:0.011930:0.005215:0.012565:0.011161:0.012027:0.006889:0.005946:0.003271:0.011873:0.006889:0.007254:0.003271:0.006889:0.007254:0.012565:0.007254:0.011873:0.012027:0.017472:0.006388
pound word that integrates diagnostics and :@0.524249:0.251639:0.920509:0.251639:0.920509:0.235883:0.524249:0.235883:0.012546:0.012027:0.011122:0.011161:0.012604:0.005542:0.015413:0.012027:0.005099:0.012604:0.005542:0.005946:0.011161:0.012565:0.005946:0.005542:0.003271:0.011161:0.005946:0.011930:0.012373:0.005215:0.012565:0.005946:0.011930:0.006889:0.005542:0.012604:0.003271:0.012565:0.012373:0.011161:0.012027:0.006889:0.005946:0.003271:0.011873:0.006889:0.005542:0.012565:0.011161:0.013183:0.005330
therapeutics in patient management. In :@0.524249:0.267938:0.920486:0.267938:0.920486:0.252182:0.524249:0.252182:0.005946:0.011161:0.011930:0.005215:0.012565:0.012546:0.011930:0.011122:0.005946:0.003271:0.011873:0.006889:0.014470:0.003271:0.011161:0.014470:0.012546:0.012565:0.005946:0.003271:0.011930:0.011161:0.005946:0.014470:0.017472:0.012565:0.011161:0.012565:0.012373:0.011930:0.017472:0.011930:0.011161:0.005946:0.004753:0.014470:0.003772:0.011736:0.005330
theranostics, a radiopharmaceutical is used :@0.524249:0.284236:0.920502:0.284236:0.920502:0.268480:0.524249:0.268480:0.005946:0.011161:0.011930:0.005215:0.012565:0.011161:0.012027:0.006889:0.005946:0.003271:0.011873:0.006889:0.004753:0.006465:0.012565:0.006465:0.005215:0.012565:0.012604:0.003271:0.012027:0.012546:0.011161:0.012565:0.005746:0.017472:0.012565:0.011873:0.011930:0.011122:0.005946:0.003271:0.011873:0.012565:0.003271:0.006465:0.003271:0.006889:0.006465:0.011122:0.006889:0.011930:0.013183:0.005330
for the diagnostic imaging of a disease and :@0.524249:0.300534:0.920494:0.300534:0.920494:0.284778:0.524249:0.284778:0.005465:0.012027:0.005215:0.005952:0.005946:0.011161:0.011930:0.005952:0.012604:0.003271:0.012565:0.012373:0.011161:0.012027:0.006889:0.005946:0.003271:0.011873:0.005952:0.003271:0.017472:0.012565:0.012373:0.003271:0.011161:0.012373:0.005952:0.012027:0.005465:0.005952:0.012565:0.005952:0.012604:0.003271:0.006889:0.011930:0.012565:0.006889:0.011930:0.005954:0.012565:0.011161:0.013183:0.005330
a variation of the same molecule is used for :@0.524249:0.316833:0.920542:0.316833:0.920542:0.301077:0.524249:0.301077:0.012565:0.006004:0.010083:0.012565:0.005215:0.003271:0.012565:0.005946:0.003271:0.012027:0.011161:0.006004:0.012027:0.005465:0.006004:0.005946:0.011161:0.011930:0.006004:0.006889:0.012565:0.017472:0.011930:0.006004:0.017472:0.012027:0.003271:0.011930:0.011873:0.011122:0.003271:0.011930:0.006004:0.003271:0.006889:0.006004:0.011122:0.006889:0.011930:0.012604:0.006004:0.005465:0.012027:0.005788:0.005330
the treatment of the disease.:@0.524249:0.333131:0.778266:0.333131:0.778266:0.317375:0.524249:0.317375:0.005946:0.011161:0.011930:0.004753:0.005946:0.005136:0.011930:0.012565:0.005946:0.017472:0.011930:0.011161:0.005946:0.004753:0.012027:0.005465:0.004753:0.005946:0.011161:0.011930:0.004753:0.012604:0.003271:0.006889:0.011930:0.012565:0.006889:0.011930:0.005330
Theranostics involves the following::@0.524249:0.365728:0.846617:0.365728:0.846617:0.349972:0.524249:0.349972:0.008197:0.011738:0.012508:0.005792:0.013143:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.007466:0.005330:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.007466:0.005330:0.006523:0.011738:0.012508:0.005330:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330
n   :@0.524242:0.378954:0.547050:0.378954:0.547050:0.370514:0.524242:0.370514:0.009762:0.003566:0.005914:0.003566
Localisation of site disease and :@0.543484:0.382074:0.837412:0.382074:0.837412:0.366318:0.543484:0.366318:0.008890:0.012604:0.012450:0.013143:0.003848:0.003848:0.007466:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.007466:0.003848:0.006523:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330
determining its extent (staging):@0.543484:0.398372:0.832376:0.398372:0.832376:0.382616:0.543484:0.382616:0.013181:0.012508:0.006523:0.012508:0.006317:0.018049:0.003848:0.011738:0.003848:0.011738:0.012950:0.005330:0.003848:0.006523:0.007466:0.005330:0.012508:0.009236:0.006523:0.012508:0.011738:0.006523:0.005330:0.007100:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.007100
n   :@0.524242:0.411553:0.547050:0.411553:0.547050:0.403112:0.524242:0.403112:0.009762:0.003566:0.005914:0.003566
Determination of expression of the :@0.543484:0.414672:0.868057:0.414672:0.868057:0.398916:0.543484:0.398916:0.014316:0.012508:0.006523:0.012508:0.006319:0.018049:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.012508:0.009236:0.013123:0.005700:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330
biological target in the tumour. Only :@0.543484:0.430970:0.884419:0.430970:0.884419:0.415214:0.543484:0.415214:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.006523:0.013143:0.005811:0.012950:0.012508:0.006523:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.004347:0.005330:0.005330:0.016722:0.011738:0.003848:0.010314:0.005330
patients whose tumours overexpress :@0.543484:0.447268:0.883295:0.447268:0.883295:0.431512:0.543484:0.431512:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.015990:0.011738:0.012604:0.007466:0.012508:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.012604:0.010660:0.012508:0.005690:0.012508:0.009236:0.013123:0.005711:0.012508:0.007466:0.007466:0.005330
the biological target will respond to :@0.543484:0.463567:0.878933:0.463567:0.878933:0.447811:0.543484:0.447811:0.006523:0.011738:0.012508:0.005330:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.006523:0.013143:0.005792:0.012950:0.012508:0.006523:0.005330:0.015990:0.003848:0.003848:0.003848:0.005330:0.005711:0.012508:0.007466:0.013123:0.012604:0.011738:0.013181:0.005330:0.006523:0.012604:0.005330
targeted radionuclide therapy:@0.543484:0.479865:0.828266:0.479865:0.828266:0.464109:0.543484:0.464109:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
n   :@0.524242:0.493048:0.547050:0.493048:0.547050:0.484608:0.524242:0.484608:0.009762:0.003566:0.005914:0.003566
Examination of off-target distribution :@0.543484:0.496167:0.886403:0.496167:0.886403:0.480411:0.543484:0.480411:0.010314:0.009236:0.013143:0.018049:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.012604:0.006084:0.006042:0.006388:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.005330:0.013181:0.003848:0.007466:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.003848:0.012604:0.011738:0.005330
of the agent. This is the cause of side :@0.543484:0.512466:0.889309:0.512466:0.889309:0.496710:0.543484:0.496710:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.013143:0.012950:0.012508:0.011738:0.006523:0.005330:0.005330:0.008197:0.011738:0.003848:0.007466:0.005330:0.003848:0.007466:0.005330:0.006523:0.011738:0.012508:0.005330:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330:0.012604:0.006042:0.005330:0.007466:0.003848:0.013181:0.012508:0.005330
effects:@0.543484:0.528764:0.607077:0.528764:0.607077:0.513008:0.543484:0.513008:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466
n   :@0.524242:0.541946:0.547050:0.541946:0.547050:0.533506:0.524242:0.533506:0.009762:0.003566:0.005914:0.003566
Determination of the amount of :@0.543484:0.545065:0.845617:0.545065:0.845617:0.529309:0.543484:0.529309:0.014316:0.012508:0.006523:0.012508:0.006319:0.018049:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.013143:0.018049:0.012604:0.011699:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330
therapeutic radiopharmaceuticals :@0.543484:0.561363:0.872010:0.561363:0.872010:0.545607:0.543484:0.545607:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.013123:0.011738:0.013143:0.006312:0.018049:0.013143:0.012450:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.007466:0.005330
required for treatment in a particular :@0.543484:0.577662:0.889497:0.577662:0.889497:0.561906:0.543484:0.561906:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.005330:0.006042:0.012604:0.005792:0.005330:0.006523:0.005694:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.003848:0.011738:0.005330:0.013143:0.005330:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330
patient:@0.543484:0.593960:0.610890:0.593960:0.610890:0.578204:0.543484:0.578204:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523
n   :@0.524242:0.607142:0.547050:0.607142:0.547050:0.598702:0.524242:0.598702:0.009762:0.003566:0.005914:0.003566
Monitoring response to treatment after :@0.543484:0.610261:0.908915:0.610261:0.908915:0.594505:0.543484:0.594505:0.017684:0.012604:0.011738:0.003848:0.006523:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330:0.005694:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.005330:0.006523:0.012604:0.005330:0.006523:0.005696:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.013143:0.006042:0.006523:0.012508:0.005792:0.005330
targeted radionuclide therapy:@0.543484:0.626560:0.828266:0.626560:0.828266:0.610804:0.543484:0.610804:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
Theranostics  epitomises the  concept  of :@0.524242:0.659156:0.920483:0.659156:0.920483:0.643400:0.524242:0.643400:0.008197:0.011738:0.012508:0.005792:0.013143:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.007466:0.005330:0.006837:0.012508:0.013123:0.003848:0.006523:0.012604:0.018049:0.003848:0.007466:0.012508:0.007466:0.012180:0.006523:0.011738:0.012508:0.005330:0.006841:0.012450:0.012604:0.011738:0.012450:0.012508:0.013123:0.006523:0.005330:0.006837:0.012604:0.006042:0.005330
personalised care in cancer treatment. :@0.524242:0.675455:0.920476:0.675455:0.920476:0.659699:0.524242:0.659699:0.013123:0.012508:0.005792:0.007466:0.012604:0.011738:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.011911:0.012450:0.013143:0.005715:0.012508:0.011911:0.003848:0.011738:0.011911:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011911:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330
Only patients who will benefit from radio-:@0.524242:0.691753:0.915147:0.691753:0.915147:0.675997:0.524242:0.675997:0.016722:0.011738:0.003848:0.010314:0.007075:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007068:0.015990:0.011738:0.012604:0.007062:0.015990:0.003848:0.003848:0.003848:0.007081:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006514:0.007068:0.006042:0.005713:0.012604:0.018049:0.007064:0.005792:0.013143:0.013181:0.003848:0.012604:0.006388
nuclide therapy are treated. This ensures :@0.524242:0.708051:0.920493:0.708051:0.920493:0.692295:0.524242:0.692295:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.008274:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.008274:0.013143:0.005715:0.012508:0.008274:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330:0.008274:0.008197:0.011738:0.003848:0.007466:0.008274:0.012508:0.011738:0.007466:0.011699:0.005711:0.012508:0.007466:0.005330
rational use of scarce resources and pre-:@0.524242:0.724350:0.915153:0.724350:0.915153:0.708594:0.524242:0.708594:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.007068:0.011699:0.007466:0.012508:0.007070:0.012604:0.006042:0.007066:0.007466:0.012450:0.013143:0.005661:0.012450:0.012508:0.007070:0.005711:0.012508:0.007466:0.012604:0.011699:0.005653:0.012450:0.012508:0.007466:0.007072:0.013143:0.011738:0.013181:0.007072:0.013123:0.005715:0.012508:0.006388
vents adverse effects relating to the use of :@0.524242:0.740648:0.920506:0.740648:0.920506:0.724892:0.524242:0.724892:0.010660:0.012508:0.011738:0.006523:0.007466:0.004676:0.013143:0.013181:0.010660:0.012508:0.005792:0.007466:0.012508:0.004676:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.004676:0.005711:0.012508:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.004676:0.006523:0.012604:0.004664:0.006523:0.011738:0.012508:0.004662:0.011699:0.007466:0.012508:0.004676:0.012604:0.006042:0.005330
ineffective treatment in patients who may :@0.524242:0.756946:0.920476:0.756946:0.920476:0.741190:0.524242:0.741190:0.003848:0.011738:0.012508:0.006098:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.003848:0.011738:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.015990:0.011738:0.012604:0.005330:0.018049:0.013143:0.010314:0.005330
not benefit from it.:@0.524242:0.773245:0.694953:0.773245:0.694953:0.757489:0.524242:0.757489:0.011738:0.012604:0.006523:0.005330:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.005330:0.006042:0.005688:0.012604:0.018049:0.005330:0.003848:0.006523:0.005330
Targeted  radionuclide  therapy  started :@0.542426:0.789543:0.920487:0.789543:0.920487:0.773787:0.542426:0.773787:0.007197:0.013143:0.005809:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.005598:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.005607:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005601:0.007466:0.006523:0.013143:0.005792:0.006523:0.012508:0.013181:0.005330
more than 70 years ago with the  use of :@0.524242:0.805841:0.920504:0.805841:0.920504:0.790085:0.524242:0.790085:0.018049:0.012604:0.005709:0.012508:0.008813:0.006523:0.011738:0.013143:0.011738:0.008813:0.010660:0.010660:0.008813:0.010314:0.012508:0.013143:0.005792:0.007466:0.008813:0.013143:0.012950:0.012604:0.008813:0.015990:0.003848:0.006523:0.011738:0.008813:0.006523:0.011738:0.012508:0.005330:0.003473:0.011699:0.007466:0.012508:0.008813:0.012604:0.006042:0.005330
radioactive iodine in the treatment of :@0.524242:0.822140:0.920476:0.822140:0.920476:0.806384:0.524242:0.806384:0.005792:0.013143:0.013181:0.003848:0.012604:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.013450:0.003848:0.012604:0.013181:0.003848:0.011738:0.012508:0.013450:0.003848:0.011738:0.013450:0.006523:0.011738:0.012508:0.013450:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.013450:0.012604:0.006042:0.005330
benign  and  malignant  thyroid  diseases.  :@0.524242:0.838438:0.920481:0.838449:0.920481:0.822693:0.524242:0.822682:0.013123:0.012508:0.011738:0.003848:0.012950:0.011738:0.005330:0.004391:0.013143:0.011738:0.013181:0.005330:0.004397:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.004397:0.006523:0.011738:0.010314:0.005709:0.012604:0.003848:0.013181:0.005330:0.004397:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007466:0.005330:0.006226:-0.657250
1:@0.908933:0.832830:0.915148:0.832830:0.915148:0.823644:0.908933:0.823644:0.006215
Since then, many other radiopharmaceu-:@0.524241:0.854747:0.915151:0.854747:0.915151:0.838991:0.524241:0.838991:0.009583:0.003848:0.011738:0.012450:0.012508:0.005857:0.006523:0.011738:0.012508:0.011738:0.005330:0.005850:0.018049:0.013143:0.011738:0.010314:0.005859:0.012604:0.006523:0.011738:0.012508:0.005792:0.005842:0.005792:0.013143:0.013181:0.003848:0.012604:0.013123:0.011738:0.013143:0.006321:0.018049:0.013143:0.012450:0.012508:0.011699:0.006388
ticals have been developed and success-:@0.524241:0.871046:0.915126:0.871046:0.915126:0.855290:0.524241:0.855290:0.006523:0.003848:0.012450:0.013143:0.003848:0.007466:0.005132:0.011738:0.013143:0.010660:0.012508:0.005118:0.013123:0.012508:0.012508:0.011738:0.005118:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.012508:0.013181:0.005118:0.013143:0.011738:0.013181:0.005118:0.007466:0.011699:0.012450:0.012450:0.012508:0.007466:0.007466:0.006388
fully used in the treatment of human can-:@0.524241:0.887344:0.915162:0.887344:0.915162:0.871588:0.524241:0.871588:0.006042:0.011699:0.003848:0.003848:0.010314:0.006004:0.011699:0.007466:0.012508:0.013181:0.006004:0.003848:0.011738:0.006004:0.006523:0.011738:0.012508:0.005994:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005990:0.012604:0.006042:0.006004:0.011738:0.011699:0.018049:0.013143:0.011738:0.006004:0.012450:0.013143:0.011738:0.006388
cers. This focus review will briefly elucidate :@0.524241:0.903642:0.920487:0.903642:0.920487:0.887886:0.524241:0.887886:0.012450:0.012508:0.005792:0.007466:0.005330:0.005403:0.008197:0.011738:0.003848:0.007466:0.005417:0.006042:0.012604:0.012450:0.011699:0.007466:0.005405:0.005713:0.012508:0.010660:0.003848:0.012508:0.015990:0.005413:0.015990:0.003848:0.003848:0.003848:0.005423:0.013123:0.005792:0.003848:0.012508:0.004666:0.004666:0.010314:0.005409:0.012508:0.003848:0.011699:0.012450:0.003848:0.013181:0.013143:0.006523:0.012508:0.005330
the recent advances in targeted radionu-:@0.524241:0.919941:0.915151:0.919941:0.915151:0.904185:0.524241:0.904185:0.006523:0.011738:0.012508:0.005455:0.005713:0.012508:0.012450:0.012508:0.011738:0.006523:0.005453:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.007466:0.005465:0.003848:0.011738:0.005465:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005455:0.005792:0.013143:0.013181:0.003848:0.012604:0.011738:0.011699:0.006388
clide therapy of cancers.:@0.524241:0.936239:0.758729:0.936239:0.758729:0.920483:0.524241:0.920483:0.012450:0.003848:0.003848:0.013181:0.012508:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.012604:0.006042:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330
Recent Advances in Targeted :@0.084848:0.111850:0.709157:0.111850:0.709157:0.076219:0.084848:0.076219:0.024801:0.027367:0.027367:0.027367:0.025657:0.012828:0.011973:0.031643:0.028222:0.023946:0.028222:0.025657:0.027367:0.027367:0.018815:0.011973:0.010263:0.025657:0.011973:0.017960:0.028222:0.013683:0.028222:0.027367:0.012828:0.027367:0.028222:0.011973
Radionuclide Therapy of Cancers: :@0.084848:0.144188:0.798100:0.144188:0.798100:0.108557:0.084848:0.108557:0.024801:0.028222:0.028222:0.010263:0.027367:0.025657:0.025657:0.027367:0.010263:0.010263:0.028222:0.027367:0.011973:0.017960:0.025657:0.027367:0.013683:0.028222:0.028222:0.024801:0.011973:0.027367:0.011973:0.011973:0.033354:0.028222:0.025657:0.027367:0.027367:0.013683:0.018815:0.011973:0.011973
Moving towards Personalised Care:@0.084848:0.176526:0.800666:0.176526:0.800666:0.140895:0.084848:0.140895:0.038485:0.027367:0.023946:0.010263:0.025657:0.028222:0.011973:0.012828:0.027367:0.034209:0.028222:0.013683:0.028222:0.018815:0.011973:0.023946:0.027367:0.013683:0.018815:0.027367:0.025657:0.028222:0.010263:0.010263:0.018815:0.027367:0.028222:0.011973:0.033354:0.028222:0.013683:0.027367